Skip to content
10-Q

Quarterly Report

Celularity Inc. CELU CELUW

0001641172-25-026056

← back to feed
Filed
Aug 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Aug 30, 2025 26.69M sh
Shares Diluted Q1 2025 · Mar 31, 2025 23.53M sh
Shares Diluted Q1 2025 · Mar 31, 2024 21.44M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$2.99M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.4M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $293K
Cash And Equivalents Q1 2025 · Dec 31, 2024 $738K
Stockholders Equity Q1 2025 · Mar 31, 2025 −$5.51M
Stockholders Equity Q1 2025 · Dec 31, 2024 $8.84M
Stockholders Equity Q1 2025 · Mar 31, 2024 $31.25M
Stockholders Equity Q1 2025 · Dec 31, 2023 $40.96M
Current Liabilities Q1 2025 · Mar 31, 2025 $58.69M
Current Liabilities Q1 2025 · Dec 31, 2024 $53.68M
Total Liabilities Q1 2025 · Mar 31, 2025 $134.38M
Total Liabilities Q1 2025 · Dec 31, 2024 $123.85M
Current Assets Q1 2025 · Mar 31, 2025 $22.08M
Current Assets Q1 2025 · Dec 31, 2024 $20.56M
Total Assets Q1 2025 · Mar 31, 2025 $128.88M
Total Assets Q1 2025 · Dec 31, 2024 $132.68M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.84
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.03
Eps Basic Q1 2025 · Mar 31, 2025 −$0.84
Eps Basic Q1 2025 · Mar 31, 2024 −$1.03
Sga Expense Q1 2025 · Mar 31, 2025 $14.26M
Sga Expense Q1 2025 · Mar 31, 2024 $14.03M
Rd Expense Q1 2025 · Mar 31, 2025 $3.73M
Rd Expense Q1 2025 · Mar 31, 2024 $5.84M
Net Income Q1 2025 · Mar 31, 2025 −$19.75M
Net Income Q1 2025 · Mar 31, 2024 −$22.01M
Operating Income Q1 2025 · Mar 31, 2025 −$10.49M
Operating Income Q1 2025 · Mar 31, 2024 −$7.38M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $3.55M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $1.64M
Revenue Q1 2025 · Mar 31, 2025 $11.43M
Revenue Q1 2025 · Mar 31, 2024 $14.68M
Capex Q1 2025 · Mar 31, 2024 $39K